Structure Therapeutics American Stock Statistic Functions Beta
| GPCR Stock | 58.20 -0.02 -0.03% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Structure Therapeutics correlated with the market. If Beta is less than 0 Structure Therapeutics generally moves in the opposite direction as compared to the market. If Structure Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Structure Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Structure Therapeutics is generally in the same direction as the market. If Beta > 1 Structure Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Structure Therapeutics Technical Analysis Modules
Most technical analysis of Structure Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Structure from various momentum indicators to cycle indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Structure Therapeutics is publicly traded on the NASDAQ Exchange in United States. A high-level view of Structure Therapeutics emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 2.55. Structure Therapeutics has a market cap of 3.87 B, ROE of -11.86%.
Methodology
Unless otherwise specified, financial data for Structure Therapeutics American is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Structure (USA Stocks:GPCR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Structure Therapeutics American may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Structure Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Structure Therapeutics pair trading
Pair trading with Structure Therapeutics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Structure Therapeutics Pair Trading
Structure Therapeutics American Pair Trading Analysis
Correlation analysis helps investors find suitable substitutes for Structure Therapeutics during tax-loss harvesting periods. Selling Structure Therapeutics American at a loss and immediately repurchasing it would violate IRS wash-sale rules, so a correlated replacement asset is required to maintain portfolio.
Measuring the statistical correlation of Structure Therapeutics against other instruments helps investors understand portfolio diversification. A correlation near zero implies that Structure Therapeutics provides genuine diversification benefits, while high positive correlations suggest redundant exposures.
Correlation analysis and pair trading evaluation for Structure Therapeutics can be used to frame hedging context. The context can be applied within sectors, industries, or broader universes.Additional Tools for Structure Stock Analysis
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |